Sudden death caused by fulminant bacterial infection: Background and pathogenesis of Japanese adult cases

Internal Medicine

Volumn 47, Issue 17, 2008, Pages 1499-1504

  Tajiri, Takuma ^a   Tate, Genshu ^a   Miura, Katsutoshi ^b   Masuda, Shinji ^c   Ohike, Nobuyuki ^d   Kunimura, Toshiaki ^d   Mitsuya, Toshiyuki ^a   Morohoshi, Toshio ^d  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Takaoka Municipal Hospital   (Japan)

^d SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alcoholic liver injury; Autopsy; Fulminant bacterial infection; Necrotizing fasciitis; Splenectomy

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM DETECTION; CHRONIC DISEASE; CLINICAL ARTICLE; FASCIITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; MALE; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; RISK FACTOR; SHOCK; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; SUDDEN DEATH; SYMPTOM; VIBRIO VULNIFICUS;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BACTEREMIA; BACTERIAL INFECTIONS; CHRONIC DISEASE; DEATH, SUDDEN; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STREPTOCOCCAL INFECTIONS; VIBRIO INFECTIONS;

EID: 56349095138     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1160     Document Type: Article

References (40)

1. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1-7, 1989.
2. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 269: 384-389, 1993.
3. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269: 390-391, 1993.
4. Barry W, Hudgins L. Donta ST, Pesanti EL. Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA 267: 3315-3316, 1992.
5. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335: 547-554, 1996.
6. Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 344: 1111-1115, 1994.
7. Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 103: 18-24, 1997.
8. Blake PA. Merson MH. Weaver RE. Hollis DG. Heublein PC. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med 300: 1-5, 1979.
9. Hlady WG. Mullen RC. Hopkin RS. Vibrio vulnificus from raw oysters. Leading cause of reported deaths from foodborne illness in Florida. J Fla Med Assoc 80: 536-538, 1993.
10. Tajiri T, Tate G, Akita H, et al. Autopsy cases of fulminant-type bacterial infection with necrotizing fasciitis: Group A (beta) hemolytic Streptococcus pyogenes versus Vibrio vulnificus infection. Pathol Int 57: 606-612, 2008.
11. Waghorn DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 54: 214-218, 2001.
12. Jugenburg M, Haddock G, Freedman MH, Ford-Jones L, Ein SH. The morbidity and mortality of pediatric splenectomy: does prophylaxis make a difference? J Pediatr Surg 34: 1064-1067, 1999.
13. Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post-splenectomy patients. J Infect 43: 182-186, 2001.
14. Cullingford GL, Watkins DN, Watts AD, Mallon DF. Severe late postsplenectomy infection. Br J Surg 78: 716-721, 1991.
15. Landgren O, Bjorkholm M, Konradsen HB, et al. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. J Intern Med 255: 664-673, 2004.
16. Working Party of the British Committe for Standards in Haematology Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ 312: 430-434, 1996.
17. Vicca AF. Stansfield RE, Masterlon RG. Evaluation of new streptococcal latex grouping kit. J Clin Pathol 46: 79-80, 1993.
18. Davies S, Gear JE, Mason CM, McIntyre SM, Hall L. Streptococcus grouping latex kits evaluation of five commertially available examples. Br J Biomed Sci 60: 136-140, 2003.
19. Tajiri T, Tate G, Enosawa T, et al. Chnicopathological findings in fulminant-type pneumococcal infection: report of three autopsy cases. Pathol Int 57: 606-612, 2007.
20. Bryant AE, Kehoe MA, Stevens DL. Streptococcal pyrogenic exotoxin A and streptolysin O enhance polymorphonuclear leukocyte binding to gelatin matrixes. J Infect Dis 166: 165-169, 1992.
21. Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Reemergence of emm1 and a changed superantigen profile for group. A streptococci causing invasive infections: results from a nationwide study. J Clin Microbiol 43: 1789-1796, 2005.
22. Jevon GP, Dunne WMJr, Hawkins HK, Armstrong DL. Musser JM. Fatal group A streptococcal meningitis and toxic shock-like syndrome: case report. Clin Infect Dis 18: 91-93, 1994.
23. Hor LI, Chang YK, Chang CC, Lei HY. Ou JT. Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection. Microbiol Immunol 44: 871-878, 2000.
24. Fox B. Disseminated intravascular coagulation and the Waterhouse-Friderichsen syndrome. Arch Dis Child 46: 680-685, 1971.
25. Gowda R, Razvi FM, Summerfield GP. Risk of pneumococcal septicaemia in patients with chronic lymphoproliferative malignancies. BMJ 311: 26-27, 1995.
26. Grogan TM, Van Camp B, Kyle RA. Muller-Hermelink HK, Harris NL. Plasma cell neoplasms. In: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001: 142-148.
27. Goodman J, Newman MI, Chapman WC. Disorders of the spleen. In: Wintrobe's Clinical Hematology, Greer JP, Foerster J, Lukens JN, et al. Eds. 11th edn. Lippincott, Williams & Wilkins, Philadelphia. PA, 2003: 1893-1909.
28. Lahnborg G, Friman L, Berghem L. Reticuloendotheliall function in patients with alcoholic liver cirrhosis. Scand J Gastroenterol 16: 481-489, 1981.
29. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4: 53-58, 1984.
30. Osaka K, Komatsuzaki M, Takahashi H, Sakano S, Okabe N. Vibrio vulnificus septicaemia in Japan: an estimated number of infections and physicians knowledge of the syndrome. Epidemiol Infect 132: 993-996, 2004.
31. Torres J, Bisno AL. Hyposplenism and pneumococcemia: Visualization of Diplococcus pneumoniae in the peripheral blood smear. Am J Med 55: 851-855, 1973.
32. Coonrod JD, Leach RP. Antigenemia in fulminant pneumococcemia. Ann Intent Med 84: 561-563, 1976.
33. Rytel MW, Dee TH, Ferstenfeld JE, Hensley GT. Possible pathogenetic role of capsular antigens in fulminant pneumococcal disease with disseminated intravascular coagulation (DIC). Am J Med 57: 889-896, 1974.
34. Espat NJ, Auffenberg T, Abouhamze A, Baumhofer J, Moldawer LL, Howard RJ. A role for tumor necrosis factor-alpha in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann Surg 223: 428-433, 1996.
35. Shin SH, Shin DH, Ryu PY, Chung SS. Rhee JH. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients sera. FEMS Immunol Med Microbiol 33: 133-138, 2002.
36. Sie MY, Ip-yam PC, Oon LL. Vibrio vulnificus septicaemia. Anaesth Intensive Care 30: 77-81, 2002.
37. Norrby-Teglund A, Thulin P, Gan BS, et al. Evidence for superantigen involvement in severe group A streptococcal tissue infections. J Infect Dis 184: 853-860, 2001.
38. Norrby-Teglund A, Muller MP. Mceer A, et al. Successful management of group A streptococcal soft tissue infections using an agressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis 31: 166-172, 2005.
39. Mehta S, McGeer A, Low DE, et al. Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest 130: 1679-1686, 2006.
40. Oishi H, Ura Y, Mitsumizo S, Nakashima M. A collective review of Vibrio vulnificus infection in Japan. Kansenshogaku Zasshi 80: 680-689, 2006 (in Japanese with English abstract).